(Q36635503)

15 August 2017

1 reference

title

Analysis sans frontières: can we ever make economic evaluations generalisable across jurisdictions? (English)

1 reference

15 August 2017

Mark J Sculpher

1

1 reference

15 August 2017

Michael F Drummond

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

24

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

1087-1099

1 reference

Assessing the appropriateness of combining economic data from multinational clinical trials

15 August 2017

cites work

1 reference

12 December 2020

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra

1 reference

12 December 2020

Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilities.

1 reference

12 December 2020

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

12 December 2020

Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'?

1 reference

12 December 2020

Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?

1 reference

12 December 2020

National Institute for Clinical Excellence and its value judgments

1 reference

12 December 2020

Whither trial-based economic evaluation for health care decision making?

1 reference

12 December 2020

A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

1 reference

12 December 2020

Cost-effectiveness analysis for multinational clinical trials.

1 reference

12 December 2020

Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study.

1 reference

12 December 2020

Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis

1 reference

12 December 2020

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions

1 reference

12 December 2020

Using value of information analysis to prioritise health research: some lessons from recent UK experience

1 reference

12 December 2020

Generalisability in economic evaluation studies in healthcare: a review and case studies.

1 reference

12 December 2020

Health economic guidelines--similarities, differences and some implications

1 reference

12 December 2020

Using multilevel models for assessing the variability of multinational resource use and cost data.

1 reference

12 December 2020

Analyzing differences in the costs of treatment across centers within economic evaluations.

1 reference

12 December 2020

Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty--when is there sufficient evidence?

1 reference

12 December 2020

Bayesian methods for evidence synthesis in cost-effectiveness analysis

1 reference

12 December 2020

Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models

1 reference

12 December 2020

The use of probabilistic decision models in technology assessment : the case of total hip replacement

1 reference

12 December 2020

'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data

1 reference

12 December 2020

Estimating country-specific cost-effectiveness from multinational clinical trials

1 reference

12 December 2020

The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

1 reference

12 December 2020

10.2165/00019053-200624110-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1028989702

0 references

1 reference